WAT

Waters Corp
D

WAT

306.29
USD
6.58
(2.20%)
مغلق
حجم التداول
26,936
الربح لكل سهم
13
العائد الربحي
-
P/E
28
حجم السوق
18,231,645,778
أصول ذات صلة
A
A
2.170
(1.69%)
130.700 USD
AMGN
AMGN
3.67
(1.31%)
283.64 USD
BAX
BAX
0.850
(3.60%)
24.430 USD
BDX
BDX
0.940
(0.49%)
192.350 USD
B
BIO
5.50
(1.90%)
295.24 USD
BSX
BSX
-0.100
(-0.09%)
107.210 USD
DHR
DHR
1.160
(0.58%)
200.170 USD
DXCM
DXCM
-0.240
(-0.30%)
80.530 USD
EW
EW
0.115
(0.14%)
81.080 USD
HOLX
HOLX
0.375
(0.56%)
66.765 USD
IDXX
IDXX
6.50
(1.02%)
646.72 USD
ILMN
ILMN
3.170
(3.25%)
100.820 USD
LH
LH
3.56
(1.29%)
278.62 USD
MTD
MTD
23.17
(1.80%)
1,310.06 USD
المزيد
الأخبار المقالات

العنوان: Waters Corp

القطاع: Healthcare
الصناعة: Diagnostics & Research
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.